You can’t manage what you can’t measure.
For the past several years, healthcare marketing leaders have operated with a reliable map: trackable search rankings, measurable website traffic, and visible review scores. The tools weren’t perfect, but they gave organizations a sense of where they stood and what to do about it.
That map is increasingly obsolete.
AI models are reshaping how patients discover and evaluate care—synthesizing trust signals, surfacing aggregated reputations, and forming first impressions before a patient visits a health system’s website. The visibility problem is well-documented at this point. What gets discussed far less is the measurement problem.
Most healthcare organizations have no reliable way to know how they appear in AI-generated answers. Even those using a tool that produces a score often can’t tell if that score is good or bad, or how it compares to local competitors and national brands. That gap is both an inconvenience and a strategic blind spot.
Why AI visibility is so hard to track
Traditional search visibility is straightforward to measure: You track keywords, check search rankings, and monitor website traffic. AI visibility works differently. Ask ChatGPT, Gemini, or Perplexity to recommend a cardiologist and the answer is shaped by phrasing, source data, and the moment you happen to ask. Five slightly different questions can produce five different answers, and the same prompt run the next day may shift again.
AI visibility isn’t one channel—it’s a growing set of surfaces, including Google AI Overviews, Gemini, ChatGPT, Claude, and Perplexity, each weighting reputation signals differently. Claude has become one of the fastest growing, gaining ground with professional and enterprise users. A system strong on one surface may be largely invisible on another, and in a category as competitive as orthopedics, cardiology, or oncology, that kind of partial picture is dangerous.
The measurement problem also splits into branded and unbranded territory. Branded prompts like, “What do patients say about [health system]?” show how AI characterizes you once you’re part of the conversation. Unbranded prompts like, “Best place to go for knee replacement surgery in Atlanta,” determine whether you’re mentioned at all. A strong brand can still be invisible in unbranded discovery in its own backyard.
Geography adds another layer. Healthcare is a local business—even at national scale, and AI doesn’t reliably distinguish a system dominant in one local market from a strong national or international brand like Johns Hopkins, Cleveland Clinic, or Mayo Clinic. Those brands aren’t direct competitors, but a synthesized answer can blur that line, leaning on national reputation while missing local market reality. Competitive markets run along designated market areas and hospital referral regions that cut across city and state lines, not simple city names. Phrasing alone can shift the answer. For example, “best orthopedic hospital in Cleveland” and “top orthopedic surgeons near me,” return different recommendations for one patient.
Finally, there’s no single right prompt. Market positioning, local discovery, service-line selection, patient satisfaction, and physician reputation are distinct categories. Testing them consistently against an organization’s highest-volume service lines rather than collapsing everything into a handful of generic queries is what makes results meaningful instead of misleading.
Citation tracking and the new visibility metric
There’s also a newer signal worth tracking: citations. Many AI engines cite specific sources behind their answers, which means you can see whether your own website is being cited as authoritative, or whether competitors, independent websites, or low-authority pages are filling that role. It’s a valuable layer most organizations are starting to track, but it’s only one piece of the picture.
The real opportunity is a blended visibility score built on three distinct signals.
- Brand mentions—how often your organization appears in an AI response at all, regardless of whether any source is cited. Mentions can be positive or negative; high frequency that includes unfavorable characterizations isn’t a win.
- Domain citations—whether your website, or sources you control, are being cited as the basis for an AI answer. That’s a measure of influence over the conversation.
- Citation rank—a source cited first carries more weight than one deeper in a response. Where your domain lands relative to competitors’ is a truer read of relative influence than mention volume alone.
No single metric tells the whole story—but tracking all three together, consistently, is what turns AI visibility from a blind spot into something you can manage.
What you need to know
When healthcare leaders ask the right questions about AI visibility, they tend to land on four things.
- Are we being recommended? If so, across which engines, for which query types, branded and unbranded, in the markets that matter—and where are we invisible?
- How are we being characterized when AI does mention us? Is it accurately and competitively, or shaped by outdated or inconsistent data?
- How do we compare to local and regional competitors? Visibility is relative and being present matters less if a competitor is consistently recommended first and with greater confidence to patients in your own markets.
- What’s driving the gaps? Patterns in source coverage, review volume, recency, rating consistency, and citation authority predict inclusion. Understanding those patterns is the difference between monitoring and improving.
Healthcare may be the sharpest example of this problem, but it’s far from the only one—any high-stakes, trust-dependent industry faces a version of it. The organizations that build measurement infrastructure now will have a real advantage as AI becomes the dominant layer of discovery for high-consideration decisions. You can’t manage what you can’t measure. Most organizations aren’t consistently measuring this yet.